Issue 2/2020
Content (30 Articles)
A Call for a New Paradigm for Diabetes Care in the Era of Sodium–Glucose Cotransporter 2 Inhibitors (SGLT2i)
Sun H. Kim, Tara I. Chang, Kenneth W. Mahaffey
Sex-Based Differences in Coronary and Structural Percutaneous Interventions
Ashley Mohadjer, Garrett Brown, Syed R. Shah, Charishma Nallapati, Nida Waheed, Anthony A. Bavry, Ki Park
Lipoprotein(a) and Cardiovascular Disease Prevention across Diverse Populations
Keon Pearson, Fatima Rodriguez
Cardiovascular Implications and Therapeutic Considerations in COVID-19 Infection
Gregory L. Judson, Benjamin W. Kelemen, Joyce N. Njoroge, Vaikom S. Mahadevan
Optical Coherence Tomography: Current Applications for the Assessment of Coronary Artery Disease and Guidance of Percutaneous Coronary Interventions
Timo T. M. Oosterveer, Sander M. van der Meer, Roderick W. C. Scherptong, J. Wouter Jukema
Vaccines Targeting PSCK9 for the Treatment of Hyperlipidemia
Stefan Toth, Dominik Pella, Jan Fedacko
Hypochloraemia in Patients with Heart Failure: Causes and Consequences
Joseph J. Cuthbert, Sunil Bhandari, Andrew L. Clark
Dual Antiplatelet Therapy in Coronary Artery Disease
Raghav Sharma, Prathap Kumar, S. P. Prashanth, Yogesh Belagali
Myocardial Fibrosis in Heart Failure: Anti-Fibrotic Therapies and the Role of Cardiovascular Magnetic Resonance in Drug Trials
Matthew Webber, Stephen P. Jackson, James C. Moon, Gabriella Captur
Expansion of TAVR into Low-Risk Patients and Who to Consider for SAVR
Kunal V. Patel, Wally Omar, Pedro Engel Gonzalez, Michael E. Jessen, Lynn Huffman, Dharam J. Kumbhani, Anthony A. Bavry
Effectiveness of Trimetazidine in Patients with Stable Angina Pectoris of Various Durations: Results from ODA
Maria G. Glezer, Vladimir A. Vygodin
Perceptions and Experiences of Atrial Fibrillation Patients on Their Condition and Oral Anticoagulant Treatment
Marcel Slavenburg, Janneke H. van den Bent, Thierry Barten, Margje Reijs-Scheijgrond, Constance de Koning
A Qualitative Analysis of Patient-Related Factors Associated With Implantable Cardioverter Defibrillator Acceptance
Amber E. Johnson, Yamira K. Bell, Megan E. Hamm, Samir F. Saba, Larissa Myaskovsky
In-Hospital Outcomes of Patients with Acute Decompensated Heart Failure and Cirrhosis: An Analysis of the National Inpatient Sample
Yaser S. Khalid, Debashis Reja, Neethi R. Dasu, Herman P. Suga, Kirti N. Dasu, Lucy M. Joo
A Comparison of Ezetimibe and Evolocumab for Atherogenic Lipid Reduction in Four Patient Populations: A Pooled Efficacy and Safety Analysis of Three Phase 3 Studies
Michael J. Koren, Peter H. Jones, Jennifer G. Robinson, David Sullivan, Leslie Cho, Thomas Hucko, J. Antonio G. Lopez, Alex N. Fleishman, Ransi Somaratne, Erik Stroes
Use, Persistence, Efficacy, and Safety of Apixaban in Patients with Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry
Uwe Zeymer, Christiane Lober, Andreas Wolf, Frank Richard, Heinrich Schäfer, Jens Taggeselle, Hans-Joachim Kabitz, Roland Prondzinsky, Tim Süselbeck
In-Hospital Outcomes of Patients With Pulmonary Hypertension and Cirrhosis: A 6-Year Population Cohort Study of Over One Million Patients
Yaser Khalid, Neethi Dasu, Raja Fawad Zafar, Herman Suga, Kirti Dasu, Brian Blair
The Effect of Low-Dose Ticagrelor on Platelet Function Profiles in Patients With Stable Coronary Artery Disease in Trinidad: The TWIST Pilot Study
Naveen Seecheran, Brent Boodhai, Aarti Maharaj, Arvinash Ramdeen, Niranjan Debideen, Vishesh Ochalal, Randall Singh, Rajeev Seecheran, Valmiki Seecheran, Sangeeta Persad, Harun Abdullah, Lakshmipathi Peram, Shastri Motilal, Antonio Tello-Montoliu, David Schneider
Efficacy and Safety of Ivabradine Once-Daily Prolonged-Release versus Twice-Daily Immediate-Release Formulation in Patients with Stable Chronic Heart Failure with Systolic Dysfunction: A Randomized, Double-Blind, Phase 3 Non-Inferiority (PROFICIENT) Study
Ajit Mullasari, Ajay Mahajan, B. B. Chanana, Dhiman Kahali, Dinesha Basavanna, Divya Prakash, Manoj Chopda, Milind Gadkari, Mukul Misra, Rajendra Kumar Premchand, Rajpal K. Abhaichand, Rakesh Kumar Aggarwal, Santanu Guha, G. Sengottuvelu, Subhash Chandra, Sudeep Kumar, Tejas Patel, Uday Kumar Hosad, Upendra Kaul, R. V. Vijay Bhaskar
Safety and Effectiveness of Hydroxychloroquine and Azithromycin Combination Therapy for Treatment of Hospitalized Patients with COVID-19: A Propensity-Matched Study
Henry D. Huang, Hani Jneid, Mariam Aziz, Venkatesh Ravi, Parikshit S. Sharma, Timothy Larsen, Neal Chatterjee, Basil Saour, Zaid Aziz, Hemal Nayak, Richard G. Trohman, Kousik Krishnan
Home-Based Cardiac Rehabilitation (HBCR) In Post-TAVR Patients: A Prospective, Single-Center, Cohort, Pilot Study
Gurjaspreet K. Bhattal, Ki E. Park, David E. Winchester
Overuse of Cardiac Troponin Among Hospitalized Patients: A Cohort Study of Biomarker “Superusers”
Sean M. Taasan, David E. Winchester
Clinical Characteristics and In-Hospital Mortality for COVID-19 Across The Globe
Sunny Goel, Tarun Jain, Amit Hooda, Rohit Malhotra, Gurpreet Johal, Reza Masoomi, Haroon Kamran, Parasuram Melarcode Krishnamoorthy, Nagendra Boopathy Senguttuvan, Abhishek Sharma, Umesh Gidwani
A Phase 4, Open-Label, Single-Arm Study Assessing the Efficacy and Safety of Ivabradine in African American Patients with Heart Failure and Reduced Ejection Fraction
David E. Lanfear, Kelsey R. Neaton, Chen Lu, Yimeng Liu, Ricardo E. Dent-Acosta
Acute Myocarditis After Black Widow Spider Bite: A Case Report
A. Piscopo, F. Massari, P. Scicchitano, M. Sanasi, M. De Palo, P. Caldarola, M. Liccese, G. Calculli
Massive Left Atrial Myxoma Presenting With Troponin-Positive Chest Pain
Aileen Kearney, Niall Corry, Ian B. A. Menown